Prediction driven design of hERG liability free compounds - webcast
The new ChemAxon ADMET plugin group builds on the power of machine learning methods on curated data sets to support the drug design and medicinal chemistry optimization with reliable models and predictions. The first available pre-trained model is targeting the elimination of cardiotoxicity risk during drug discovery by predicting hERG inhibition.
In the presentation below, we demonstrate the model development and assessment data on our hERG pAct regression model. We also discuss the requirements of modern applications interfacing with machine learning models that lead to higher detail prediction results, such as estimated error, applicability domain, and the visualization of similar training compounds.
Related content
Automated model building using only relevant features
Accelerate your drug discovery process: Create multiple models effortlessly with Trainer Engine and...
Predicting pKa
One of the most important physicochemical properties of small molecules and macromolecules are the...
Calculate on the cloud
In order to increase the flexibility, access and integrability, Calculators and Predictors have...
ICCS 2022 - Translating data to predictive models
Biological, chemical and physical properties of molecules are encoded in their molecular structure....